Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- European shares subdued as surging crude sharpens focus on ECB rate path
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Sotera Health (SHC) PT Raised to $20 at Citi
November 5, 2024 3:41 PM ESTCiti analyst Patrick Donnelly raised the price target on Sotera Health (NASDAQ: SHC) to $20.00 (from $18.00) while maintaining a Buy rating.
The analyst comments "The moving pieces within the FY24 guide were the primary focus of the 3Q call. Management reaffirmed the FY24 top- and... More
Sotera Health Co. (SHC) Misses Q3 EPS by 1c, Beats on Revenue
November 5, 2024 7:05 AM ESTSotera Health Co. (NASDAQ: SHC) reported Q3 EPS of $0.17, $0.01 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $285 million versus the consensus estimate of $278.34 million.
For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.
... More
